Joseph Lewis, 10% Owner, Director at Odonate Therapeutics, Inc. (ODT), bought 215,200 shares at $13.03 ($2.9M) on 2020-09-28, disclosed to the SEC on 2020-09-30.
Open-market purchase of $2.9M ODT by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 93,200 | $1.2M | 41.4% |
| 2 | $14.08 | 122,000 | $1.7M | 58.6% |
| Total | $13.63 avg | 215,200 | $2.9M | 100% |
| Filing → |
| MRTX | SELL | 2020-10-30 | $154.5M | — | Filing → |
| ODT | BUY | 2020-09-09 | $3.4M | — | Filing → |
| INSG | BUY | 2018-12-20 | $29.3M | — | Filing → |